Help
RSS
API
Feed
Maltego
Contact
Domain > www.bio-itworld.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2019-11-22
192.225.209.8
(
ClassC
)
2024-07-14
205.174.27.110
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyContent-Type: text/html; charsetUTF-8Location: https://www.bio-itworld.com/X-Server: 2Date: Sun, 14 Jul 2024 02:32:37 GMTContent-Length: 151 head>title>Document Moved/title>/head>body>h1>Object Moved/h1>This document may be found a HREFhttps://www.bio-itworld.com/>here/a>/body>
Port 443
HTTP/1.1 200 OKVary: Accept-EncodingCache-Control: no-cacheContent-Type: text/html; charsetutf-8X-Server: 3Date: Sun, 14 Jul 2024 02:32:38 GMTExpires: -1Pragma: no-cacheContent-Length: 60246 !DOCTYPE html> html langen> head> meta http-equivX-UA-Compatible contentIEedge,chrome1 /> meta charsetutf-8 />script typetext/html idsf-tracking-consent-manager> style> /*Consent Form*/ #tracking-consent-dialog { padding: 15px; position: fixed; bottom: 0; right: 5px; width: 337px; border: 3px solid #1e82e0; border-radius: 5px 5px 0px 0px; background: rgba(255, 255, 255, .95); font-size: 16px; z-index: 999; } #tracking-consent-dialog-accept { background-color: #1e82e0; color: #fff; font-size: 16px; font-weight: 500; float: right; } .consent-close { font-weight: bold; float: right; padding: 2px 7px; right: 6px; top: 3px; cursor: pointer; font-size: 11px; position: absolute; background-color: #1e82e0; color: #fff; z-index: 999; border-radius: 50%; } @media (max-width: 767px) { #tracking-consent-dialog { width: 100%; font-size: 14px; } } /style> div idtracking-consent-dialog> div classconsent-close onclickTrackingConsentManager.updateUserConsent(true)>X/div> strong>Cookie Policy/strong> p>CII uses cookies to improve your website & conference experiences, including enhancing website navigation, personalized features & promotions, evaluating our services, and customizing content and ads based on your preferences as you browse or engage with us. By clicking Continue or continuing to use our site, you are agreeing to our and our partners use of cookies. See our a hrefhttps://www.cambridgeinnovationinstitute.com/Privacy-Policy/>Privacy Policy/a> for more information./p> button typebutton onclickTrackingConsentManager.updateUserConsent(true) idtracking-consent-dialog-accept classbtn btn-default>Continue/button> /div>/script>script typetext/javascript src/WebResource.axd?dDzHrpQl5URXarFHAtrmzFrNeeCwCLwHK2gvGZ95fW9WnidZLXrfDlGTuxUr3l463ttkzDVh9D8Bug9pu7NHdr_V4jKJPpR5aBflu4f8Ts5edKoXW2sH8LcSZSfqlYNJ5LpoUn5WBE_fdKcz0yNVMxY3w_4XLcip6ESbZeM3DDdUqeeNFFCEiKQKGKqR186oo0&t637922505220000000>/script> script src/ScriptResource.axd?dokuX3IVIBwfJlfEQK32K3iZZtiInnD21Q3naS01thH9-fzUaksT1ZtMUjWfsR2IfFrdwuSgx30ngwb9MjfyLwf8qicr33ktg3mwcpW2o3dsDH8d3-t4otTq9qT-5mrFfzK1f5nCn185AY5nCZScdoqJ1WOdlA_-4T4B_v3AbufPsc2J5Jr9-kOiHGAB_hap-0&t4e1c7b51 typetext/javascript>/script>script src/ScriptResource.axd?dEydukmxBmDstn7gSYzQESGX1Bc6SUabUViYB9LpdmFW6eZLmGFNo26FA-YqkH5f3QjtPWjAHxth32_ExmLGGY1zv6AdaQenYAqaM29qW1bTxx1r5T--aFytKsL9IQMjnWBhhM3Ox0iMnCMCJK5xrzQardvmrid9DGkma-HwbE57flKsxZSkIFbT-h8oEIp2m0&t4e1c7b51 typetext/javascript>/script>link href/ResourcePackages/Bootstrap/assets/dist/css/main.min.css relstylesheet typetext/css />link href/css/global-pub.css relstylesheet typetext/css />link href/css/editor.css relstylesheet typetext/css /> link href//fonts.googleapis.com/css?familyRoboto:500,400,700 relstylesheet typetext/css> meta nameviewport contentwidthdevice-width, initial-scale1, minimum-scale1, maximum-scale1, user-scalableno /> title> Bio-IT World | Biotech & Personalized Medicine News/title>meta propertyog:title contentBio-IT World | Biotech & Personalized Medicine News />meta propertyog:description contentYour trusted resource for biotech research. Read about bioinformatics, drug discovery, next-gen sequencing, cloud computing, genomics, and more! />meta propertyog:url contenthttps://www.bio-itworld.com />meta propertyog:type contentwebsite />meta propertyog:site_name contentPubs - Bio-IT World />script typetext/javascript>(function(w,d,s,l,i){wlwl||;wl.push({gtm.start:new Date().getTime(),event:gtm.js});var fd.getElementsByTagName(s)0,jd.createElement(s),dll!dataLayer?&l+l:;j.asynctrue;j.srchttps://www.googletagmanager.com/gtm.js?id+i+dl;f.parentNode.insertBefore(j,f);})(window,document,script,dataLayer,GTM-TJLJLL4);/script>script typetext/javascript srchttps://securepubads.g.doubleclick.net/tag/js/gpt.js>/script>script typetext/javascript> var googletag googletag || {}; googletag.cmd googletag.cmd || ; googletag.cmd.push(function() { googletag.defineSlot(/305762/site169.tmus, 728, 90, div-gpt-ad-1459884088267-1).addService(googletag.pubads()); googletag.defineSlot(/305762/site169.tmus, 728, 90, div-gpt-ad-1459884088267-21).addService(googletag.pubads()); googletag.defineSlot(/305762/site169.tmus, 234, 60, div-gpt-ad-1459884088267-2).addService(googletag.pubads()); googletag.defineSlot(/305762/site169.tmus, 234, 60, div-gpt-ad-1459884088267-22).addService(googletag.pubads()); googletag.defineSlot(/305762/site169.tmus, 336, 280, div-gpt-ad-1459884088267-3).addService(googletag.pubads()); googletag.defineSlot(/305762/site169.tmus, 336, 280, div-gpt-ad-1459884088267-23).addService(googletag.pubads()); googletag.defineSlot(/305762/site169.tmus, 160, 160, div-gpt-ad-1459884088267-4).addService(googletag.pubads()); googletag.defineSlot(/305762/site169.tmus, 150, 800, div-gpt-ad-1459884088267-5).addService(googletag.pubads()); googletag.defineSlot(/305762/site169.tmus, 160, 160, div-gpt-ad-1459884088267-6).addService(googletag.pubads()); googletag.defineSlot(/305762/site169.tmus, 160, 160, div-gpt-ad-1459884088267-7).addService(googletag.pubads()); googletag.defineSlot(/305762/site169.tmus, 160, 160, div-gpt-ad-1459884088267-8).addService(googletag.pubads()); googletag.pubads().enableSingleRequest(); googletag.enableServices(); });/script>script typetext/javascript srchttps://platform.twitter.com/widgets.js>/script>link href/css/pubs/bio-it.css mediaall relstylesheet typetext/css />style typetext/css mediaall>.navbar-default .navbar-nav>li:first-child, .dropdown-menu>.active>a, .dropdown-menu>.active>a:focus, .navbar-default .navbar-nav>.open>a:hover, .dropdown-menu, .navbar-default .navbar-nav>.open>a, .navbar-default .navbar-nav>li>a:hover, .navbar-default .navbar-nav>.active>a:hover { background-color: #a40018; color: #fff;}/style>meta nameGenerator contentSitefinity 14.2.7900.0 DX />link relcanonical hrefhttps://www.bio-itworld.com />script typeapplication/json idsf-insight-metadata> {contentMetadata:{\Id\:\5cd605f7-32f9-4674-89ee-c8c7cb9b449a\,\ContentType\:\Page\,\Title\:\Homepage\,\CanonicalTitle\:\Homepage\,\CanonicalUrl\:\https://www.bio-itworld.com\,\CreatedOn\:\2020-03-03T16:41:00Z\,\ModifiedOn\:\2023-03-08T18:32:01Z\,\SiteName\:\Pubs - Bio-IT World\,\PageId\:\5cd605f7-32f9-4674-89ee-c8c7cb9b449a\},videosMetadata:}/script>script typeapplication/json idsf-insight-settings> {apiServerUrl:https://api.insight.sitefinity.com/,apiKey:62dc77b5-9fbc-74c6-8f79-d05463f0565e,applicationName:CII_DEC,trackingCookieDomain:,keepDecTrackingCookieOnTrackingConsentRejection:false,slidingExpirationForTrackingCookie:false,maxAgeForTrackingCookieInDays:365,trackYouTubeVideos:true,strategy:Persist|False,docsHrefTestExpressions:.*\\/docs\\/.+\\.{1}.+((\\?|\\\u0026)sfvrsn.+){1}$,.+((\\?|\\\u0026)sf_dm_key.+){1}$}/script>script typetext/javascript src/WebResource.axd?dHtQyXelCu6mzSPcVcvK_BrDGcMZ2eaAwTGCTL_5l9xvo0iV9h2YYkvXanQ1uf0LidxbxWd8AzxNrppPmU7C9KnzDV98eKbg88D2zgKyY_GVq-IK4cwpq3ApmVVQHZ20G6_cSyVvbsc3d7cEOVVpoZalFAGFOo2fFcbG9u0riPX3ha1PNvfZCNU2C8dj5lXB2aevtM9BprQUEvuhENe--svD7i9F-8WutvDj5rAfLCkI1&t637922505220000000>/script>script srchttps://cdn.insight.sitefinity.com/sdk/sitefinity-insight-client.min.3.1.7.js asyncasync>/script>meta namedescription contentYour trusted resource for biotech research. Read about bioinformatics, drug discovery, next-gen sequencing, cloud computing, genomics, and more! />/head> body> div classADbody> a hrefhttps://www.executivedecisionmaking.com/?utm_sourcebio-itworld.com&utm_mediumbanner&utm_campaignEF_pls_05232024 target_blank> div classADbodyImg> /div> /a> div classmain-content> div idcph1 classcontainer internalHeader> div classrow> meta nametwitter:card contentsummary_large_image>meta nametwitter:site content@BioITWorld>meta nametwitter:image contenthttps://www.bio-itworld.com/images/librariesprovider76/home/twitter.png>noscript>iframe srchttps://www.googletagmanager.com/ns.html?idGTM-TJLJLL4 height0 width0 styledisplay:none;visibility:hidden>/iframe>/noscript>div classrow data-sf-elementRow> div classcol-sm-9> div idcphHeader_T3B9CFFA2004_Col00 classsf_colsIn pad-lr data-sf-elementColumn 1 data-placeholder-labelColumn 1>div > div classsf-Long-text >div iddiv-gpt-ad-1459884088267-1 classpad-left hidden-xs> /div>/div> /div>/div> /div> div classcol-sm-3> div idcphHeader_T3B9CFFA2004_Col01 classsf_colsIn pad-lr data-sf-elementColumn 2 data-placeholder-labelColumn 2>div > div classsf-Long-text >div iddiv-gpt-ad-1459884088267-2 classad-top-right> /div>/div> /div>/div> /div>/div>div classrow data-sf-elementRow> div classcol-sm-9> div idcphHeader_T3B9CFFA2005_Col00 classsf_colsIn pad-lr data-sf-elementColumn 1 data-placeholder-labelColumn 1>div > div classsf-Long-text >div classLogo>a href/>img src/images/librariesprovider76/home/bio-it-worldheader.jpg altBio-IT World News titleBio-IT World News classbitw-logo />/a>/div>/div> /div>/div> /div> div classcol-sm-3> div idcphHeader_T3B9CFFA2005_Col01 classsf_colsIn pad-lr data-sf-elementColumn 2 data-placeholder-labelColumn 2>div > div classsf-Long-text >div classsocial-division>div classAdLeaderBoardSocial>div classAbstract stylecolor:white;>a titleYouTube hrefhttps://www.youtube.com/bioitworld target_blank>img titleYouTube altYouTube srchttps://chi-cloud.s3.amazonaws.com/template_images/social-media-icons/youtube.png border0 stylepadding-right:5px;padding-top:5px; data-sf-ec-immutable />/a> a titleFacebook hrefhttp://www.facebook.com/bioitworld target_blank>img titleFacebook stylepadding-right:5px;padding-top:5px; altFacebook src/UploadedImages/social-media-icons/facebook.png border0 data-sf-ec-immutable />/a> a titleLinkedIn hrefhttps://www.linkedin.com/groups/3141702/ target_blank>img titleLinkedIn stylepadding-right:5px;padding-top:5px; altLinkedIn src/UploadedImages/social-media-icons/linkedin.png border0 data-sf-ec-immutable />/a> a titleTwitter hrefhttp://twitter.com/bioitworld target_blank>img border0 src/images/default-source/social/twitter-x-cii-uses_publishing-25x25px.png?sfvrsn72250fc_1 stylepadding-top:5px;padding-right:5px; titleTwitter altTwitter />/a>a titleInstagram hrefhttps://instagram.com/bioitworld target_blank>img titleInstagram stylepadding-top:5px;padding-right:5px; altInstagram src/UploadedImages/social-media-icons/instagram.png border0 data-sf-ec-immutable />/a> a titlerss href/RSS/BioIT_WorldNews_RSS.aspx target_blank>img titlerss stylepadding-top:5px; altrss src/UploadedImages/social-media-icons/rss.png border0 data-sf-ec-immutable />/a> /div>/div>/div>div classChiLogo>img src/images/librariesprovider50/template-images/a-divisiion-of-chi.png?sfvrsne724d425_2 alta-divisiion-of-chi titlea divisiion of chi data-displaymodeOriginal classimageResize />/div>/div> /div>/div> /div>/div> /div> /div> div idcph1 classcontainer> div classrow> div> div classnavbar navbar-default> div classnavbar-header> button typebutton classnavbar-toggle data-togglecollapse data-target.navbar-collapse> span classicon-bar>/span> span classicon-bar>/span> span classicon-bar>/span> /button> /div> div classcollapse navbar-collapse idbs-example-navbar-collapse-1> ul classnav navbar-nav large-nav rolemenu> li class>a href/BioIT/Subscribe.aspx target_self>Subscribe/a>/li> li classdropdown> a href# classdropdown-toggle rolebutton> News /a> ul rolemenu classdropdown-menu> li class> a href/bioit_top_headlines.aspx target_self>Latest News/a> /li> li class> a href/pressreleases target_self>View Press Releases/a> /li> li class> a href/bitw/pressreleaseform target_self>Post a Press Release/a> /li> li class> a href/bioit_reprints_form.aspx target_self>Reprint Articles/a> /li> /ul> /li> li class>a href/podcast-nav target_self>Podcast/a>/li> li classdropdown> a href# classdropdown-toggle rolebutton> Advertise /a> ul rolemenu classdropdown-menu> li class> a href/media-kit target_self>Media Kit/a> /li> li class> a href/advertising/digital-advertising target_self>Digital Advertising/a> /li> li class> a href/lead-generation target_self>Lead Generation/a> /li> li class> a href/editorial-calendar target_blank>Editorial Calendar/a> /li> li class> a href/advertise/webinars target_self>Webinars/a> /li> li class> a href/advertise/whitepapers target_self>Whitepapers/a> /li> li class> a href/advertise/podcasts target_self>Podcasts/a> /li> li class> a href/advertise-nav/view-press-releases target_self>View Press Releases/a> /li> li class> a href/advertise-nav/post-a-press-release target_self>Post a Press Release/a> /li> /ul> /li> li classdropdown> a href# classdropdown-toggle rolebutton> Free Downloads /a> ul rolemenu classdropdown-menu> li class> a href/whitepapers target_self>Whitepapers/a> /li> li class> a href/podcasts target_self>Podcasts/a> /li> li class> a href/bio-it-webinars target_self>Webinars/a> /li> li class> a href/bioit-ebooks target_self>Inside eBooks/a> /li> /ul> /li> li classdropdown> a href# classdropdown-toggle rolebutton> Events /a> ul rolemenu classdropdown-menu> li class> a href/events-nav/webinars target_self>Webinars/a> /li> li class> a href/Featured_Events.aspx target_self>Industry Events/a> /li> li class> a href/events-nav/it-conferences target_self>IT Conferences/a> /li> li class> a href/events-nav/bio-it-world-expo target_self>Bio-IT World Expo/a> /li> li class> a href/events-nav/bio-it-world-expo-west target_self>Bio-IT World Expo Europe/a> /li> /ul> /li> li classdropdown> a href# classdropdown-toggle rolebutton> About Us /a> ul rolemenu classdropdown-menu> li class> a href/about-bio-it-world target_self>Editorial Profile/a> /li> li class> a href/editorial-calender target_blank>Editorial Calender/a> /li> li class> a href/contact-us.html target_self>Contact Us/a> /li> li class> a href/submit-story target_self>Submit a story/a> /li> li class> a href/award target_self>Innovative Practices Awards/a> /li> li class> a href/linking-policy target_self>Linking Policy/a> /li> /ul> /li> li classdropdown> a href# classdropdown-toggle rolebutton> Bio-IT World Expo /a> ul rolemenu classdropdown-menu> li class> a href/bio-it-world-boston-nav target_self>Bio-IT World Boston/a> /li> li class> a href/bio-it-world-west-nav target_self>Bio-IT World Europe/a> /li> /ul> /li> /ul> /div>!-- /.navbar-collapse --> /div>/div> /div> /div> div idcph1 classcontainer internal> div classrow> div classrow data-sf-elementRow> div classcol-md-5 col-sm-6> div idContentplaceholder1_C018_Col00 classsf_colsIn pad-lr data-sf-elementColumn 1 data-placeholder-labelColumn 1>div > div classsf-Long-text >div idmyCarousel classcarousel slide data-ridecarousel>!-- Wrapper for slides --> div classcarousel-inner>div classitem active>a hrefhttps://www.bio-itworld.com/news/2021/09/13/gsk-s-digital-transformation-roadmap>img src/images/librariesprovider76/home/carousel/gsk.png classimageResize altGSK />/a>/div>div classitem>a hrefhttps://www.bio-itworld.com/news/2021/10/07/amazon-genomics-cli-is-open-source-uk-biobank-s-research-analysis-platform-live-more>img src/images/librariesprovider76/home/carousel/new-products.png classimageResize altNew-Products />/a>/div>div classitem>a hrefhttps://www.bio-itworld.com/news/2021/10/14/herophilus-aims-to-industrialize-use-of-organoids-for-drug-discovery>img src/images/librariesprovider76/home/carousel/organoids.png classimageResize altOrganoids />/a>/div>div classitem>a hrefhttps://www.bio-itworld.com/news/2021/10/05/trends-from-the-trenches-2021-where-bio-it-stands-on-digital-transformation-data-transformation-ai-ml>img src/images/librariesprovider76/home/carousel/trends.png classimageResize altTrends />/a>/div>div classitem>a hrefhttps://www.bio-itworld.com/news/2021/09/28/trends-in-the-trenches-2021-chris-dagdigian-on-security-vaporware-egnyte-and-the-data-management-culture>img src/images/librariesprovider76/home/carousel/dagdigian.png classimageResize altDagdigian />/a>/div>/div>/div>/div> /div>link href/css/NewsList.css relstylesheet />div classtab-button-div> button classtab-button tab-active left-button iddaily onclickselectNews(event, daily)>DAILY NEWS/button> button classtab-button idpress onclickselectNews(event, press)>PRESS RELEASES/button>/div>div classnews-tab> ul classlist-unstyled list-daily distinct-news> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/12/how-large-language-model-based-ai-will-transform-drug-safety-regulatory-processes titleHow Large Language Model-Based AI Will Transform Drug Safety & Regulatory Processes>How Large Language Model-Based AI Will Transform Drug Safety & Regulatory Processes/a>/h3> span classtab-date>Jul 12 | /span> b>Bio-IT World/b> | Training and validating intelligent automation systems for life sciences R&D purposes can undermine the business case. But the large language models (LLMs) used to power Generative AI (GenAI) is changing that and bolstering compliance, enabling on-the-fly data discovery, “in context” learning, and narrative extrapolation. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/12/how-large-language-model-based-ai-will-transform-drug-safety-regulatory-processes>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/10/new-biomarker-offers-hope-of-detecting-alzheimer's-in-asymptomatic-stages titleNew Biomarker Offers Hope of Detecting Alzheimer's in Asymptomatic Stages>New Biomarker Offers Hope of Detecting Alzheimers in Asymptomatic Stages/a>/h3> span classtab-date>Jul 10 | /span> b>Bio-IT World/b> | Until recently, all the available therapeutic options for treating Alzheimer’s disease were designed to reduce symptoms rather than address causes of the disease. But with two beta-amyloid antibodies now approved by the U.S. Food and Drug Administration, and tau-targeting agents in clinical trials, hopes are rising that Alzheimer’s progression can be delayed if not stopped. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/10/new-biomarker-offers-hope-of-detecting-alzheimer's-in-asymptomatic-stages>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/09/illumina-acquires-fluent-biosciences-single-cell-technology titleIllumina Acquires Fluent BioSciences Single-Cell Technology>Illumina Acquires Fluent BioSciences Single-Cell Technology/a>/h3> span classtab-date>Jul 09 | /span> b>Bio-IT World/b> | Illumina has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology. Fluent Biosciences is now a wholly owned subsidiary of Illumina and was acquired with cash on hand. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/09/illumina-acquires-fluent-biosciences-single-cell-technology>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/09/regeneron-uses-voice-to-text-for-science-first-data-digitization-efforts-for-animal-research titleRegeneron Uses Voice-to-Text for Science-First Data Digitization Efforts for Animal Research>Regeneron Uses Voice-to-Text for Science-First Data Digitization Efforts for Animal Research/a>/h3> span classtab-date>Jul 09 | /span> b>Bio-IT World/b> | When Regeneron began exploring how to digitize scientific information in lab environments, IT engineers didn’t begin by brainstorming their own ideas. They began by shadowing scientists. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/09/regeneron-uses-voice-to-text-for-science-first-data-digitization-efforts-for-animal-research>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/01/building-on-biotech-confidence-with-strategic-r-d titleBuilding On Biotech Confidence With Strategic R&D>Building On Biotech Confidence With Strategic R&D/a>/h3> span classtab-date>Jul 01 | /span> b>Bio-IT World/b> | The biotech sector has weathered some recent headwinds in the funding market but is marked by a general air of confidence as we come to close the first quarter of 2024. This confidence was noted in our recent survey of over 130 decision makers in biotech companies, where we found that despite challenging conditions, 87% of respondents reported at least some confidence and 38% were very confident in the overall success of their product. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/01/building-on-biotech-confidence-with-strategic-r-d>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/06/27/follow-the-money-foresite-capital-invests-in-groundbreaking-tech-synthesizing-therapeutic-cytokines-more titleFollow the Money: Foresite Capital Invests in Groundbreaking Tech, Synthesizing Therapeutic Cytokines, More>Follow the Money: Foresite Capital Invests in Groundbreaking Tech, Synthesizing Therapeutic Cytokines, More/a>/h3> span classtab-date>Jun 27 | /span> b>Bio-IT World/b> | Foresite Capital launches new fund for groundbreaking technologies, ranging from novel therapeutics to companies at the intersection of technology and biotechnology; Bright Peak Therapeutics intends to advance platform that allows for the conjugation of its enhanced cytokines as payloads to certain antibodies, creating novel and proprietary “Bright Peak Immunocytokines”; more. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/06/27/follow-the-money-foresite-capital-invests-in-groundbreaking-tech-synthesizing-therapeutic-cytokines-more>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/06/26/illumina-appoints-new-cco-launches-new-software-version-pacbio-launches-free-hifi-long-read-variant-frequency-database-more titleIllumina Appoints New CCO, Launches New Software Version, PacBio Launches Free HiFi Long-Read Variant Frequency Database, More>Illumina Appoints New CCO, Launches New Software Version, PacBio Launches Free HiFi Long-Read Variant Frequency Database, More/a>/h3> span classtab-date>Jun 26 | /span> b>Bio-IT World/b> | Illumina has appointed Everett Cunningham as Chief Commercial Officer (CCO) and has also announced the launch of DRAGEN v4.3, the latest version of its DRAGEN software; PacBio, in collaboration with the international Consortium for Long-Read Sequencing (CoLoRS), announced the launch of the first publicly available and free HiFi long-read variant frequency database with global representation; more. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/06/26/illumina-appoints-new-cco-launches-new-software-version-pacbio-launches-free-hifi-long-read-variant-frequency-database-more>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/06/25/unified-under-a-universal-language-the-pistoia-alliance-s-idmp-ontology titleUnified Under a Universal Language: The Pistoia Alliance’s IDMP Ontology>Unified Under a Universal Language: The Pistoia Alliance’s IDMP Ontology/a>/h3> span classtab-date>Jun 25 | /span> b>Bio-IT World/b> | Identification of Medicinal Products (IDMP) implementation greatly varies across organizations and regulatory jurisdictions, which impacts drug safety and pharmacovigilance. To ensure that organizations around the world can use a universal semantic interoperability based on FAIR data principles, the Pistoia Alliance has built an IDMP Ontology (IDMP-O Release 1), augmenting existing ISO IDMP standards set by the European Medical Agency. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/06/25/unified-under-a-universal-language-the-pistoia-alliance-s-idmp-ontology>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/06/21/when-banks-say-no-to-equipment-financing-it-s-not-the-end-of-the-story titleWhen Banks Say ‘No’ to Equipment Financing, It’s Not the End of the Story>When Banks Say ‘No’ to Equipment Financing, It’s Not the End of the Story/a>/h3> span classtab-date>Jun 21 | /span> b>Bio-IT World/b> | Thanks to emerging technologies, from generative AI to data platforms and robotic solutions, companies in the biotech and life science sectors are achieving amazing advances. But for every headline showcasing a success, there is a reminder of the abiding industry reality: countless promising companies are still struggling to acquire the equipment and technology they need to fuel product development and platform growth. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/06/21/when-banks-say-no-to-equipment-financing-it-s-not-the-end-of-the-story>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/06/19/avoiding-the-traps-and-pitfalls-of-artificial-intelligence-development titleAvoiding the Traps and Pitfalls of Artificial Intelligence Development>Avoiding the Traps and Pitfalls of Artificial Intelligence Development/a>/h3> span classtab-date>Jun 19 | /span> b>Bio-IT World/b> | Artificial intelligence (AI) was the main topic at the 2024 Bio-IT World Conference & Expo. While there was much excitement over new developments, there were also many discussions covering the obstacles that block the path to further progress—many of which have nothing to do with technology or data. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/06/19/avoiding-the-traps-and-pitfalls-of-artificial-intelligence-development>More/a> /li> /ul> ul classlist-unstyled list-press styledisplay: none> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/12/1uphealth-achieves-hitrust-implemented-1-year-(i1)-certification-to-manage-data-protection-and-mitigate-cybersecurity-threats title1upHealth Achieves HITRUST Implemented, 1-year (i1) Certification to Manage Data Protection and Mitigate Cybersecurity Threats >1upHealth Achieves HITRUST Implemented, 1-year (i1) Certification to Manage Data Protection and Mitigate Cybersecurity Threats /a>/h3> span classtab-date>Jul 12 | /span> a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/12/1uphealth-achieves-hitrust-implemented-1-year-(i1)-certification-to-manage-data-protection-and-mitigate-cybersecurity-threats>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/11/synexa-life-sciences-enrols-in-my-green-lab-certification-program titleSynexa Life Sciences Enrols in My Green Lab Certification Program>Synexa Life Sciences Enrols in My Green Lab Certification Program/a>/h3> span classtab-date>Jul 11 | /span> Synexa Life Sciences has announced its enrolment in the My Green Lab Certification Program. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/11/synexa-life-sciences-enrols-in-my-green-lab-certification-program>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/11/surfix-diagnostics-the-netherlands-cancer-institute-and-crcbioscreen-join-forces-to-validate-biomarkers-for-colorectal-cancer-screening titleSurfix Diagnostics, the Netherlands Cancer Institute and CRCbioscreen join forces to validate biomarkers for colorectal cancer screening>Surfix Diagnostics, the Netherlands Cancer Institute and CRCbioscreen join forces to validate biomarkers for colorectal cancer screening/a>/h3> span classtab-date>Jul 11 | /span> Surfix Diagnostics alongside the Netherlands Cancer Institute (NKI) and CRCbioscreen, announced a collaboration aimed at enhancing colorectal cancer (CRC) screening methods. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/11/surfix-diagnostics-the-netherlands-cancer-institute-and-crcbioscreen-join-forces-to-validate-biomarkers-for-colorectal-cancer-screening>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/11/zymo-research-launches-the-omics-discovery-grant-to-advance-rna-seq-research titleZYMO RESEARCH LAUNCHES THE OMICS DISCOVERY GRANT TO ADVANCE RNA-SEQ RESEARCH>ZYMO RESEARCH LAUNCHES THE OMICS DISCOVERY GRANT TO ADVANCE RNA-SEQ RESEARCH/a>/h3> span classtab-date>Jul 11 | /span> https://www.zymoresearch.com/blogs/press-releases/omics-discovery-grant-launch Apply for Zymo Researchs Omics Discovery Grant for cutting-edge RNA-Seq tools worth $4000. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/11/zymo-research-launches-the-omics-discovery-grant-to-advance-rna-seq-research>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/10/pascal-piedbois-md-phd-joins-one2treat-as-chief-medical-officer-to-advance-patient-centric-innovation-in-clinical-trial-design-and-market-access titlePascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access>Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access/a>/h3> span classtab-date>Jul 10 | /span> Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access. One2Treat reflects patient priorities in a single multi-facet treatment assessment, reducing trial sample size and accelerating patient access to new treatments. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/10/pascal-piedbois-md-phd-joins-one2treat-as-chief-medical-officer-to-advance-patient-centric-innovation-in-clinical-trial-design-and-market-access>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/10/cotiviti-s-quality-intelligence-earns-ncqa-certified-measures-status-for-hedis-measurement-year-2024 titleCotiviti’s Quality Intelligence Earns NCQA Certified Measures Status for HEDIS® Measurement Year 2024 >Cotiviti’s Quality Intelligence Earns NCQA Certified Measures Status for HEDIS® Measurement Year 2024 /a>/h3> span classtab-date>Jul 10 | /span> a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/10/cotiviti-s-quality-intelligence-earns-ncqa-certified-measures-status-for-hedis-measurement-year-2024>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/10/doseme-achieves-hitrust-risk-based-2-year-(r2)-certification titleDoseMe Achieves HITRUST Risk-Based, 2-year (r2) Certification >DoseMe Achieves HITRUST Risk-Based, 2-year (r2) Certification /a>/h3> span classtab-date>Jul 10 | /span> DoseMe, a leading provider of model-informed precision dosing (MIPD), announced today it has earned certified status by HITRUST for information security. HITRUST Risk-based, 2-year (r2) Certification demonstrates that the organization’s DoseMeRX has met demanding regulatory compliance and industry-defined requirements and is appropriately managing risk. This achievement places DoseMe in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks and incorporating a risk-based approach, the HITRUST Assurance Program helps organizations address security and data protection challenges through a comprehensive and flexible framework of prescriptive and scalable security controls. DoseMe remains the only model informed precision dosing platform to achieve the r2 Certification. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/10/doseme-achieves-hitrust-risk-based-2-year-(r2)-certification>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/10/personalized-obesity-care-genetic-testing-available-to-women-in-new-phenomix-sciences-and-hello-alpha-partnership titlePersonalized Obesity Care Genetic Testing Available to Women in New Phenomix Sciences and Hello Alpha Partnership>Personalized Obesity Care Genetic Testing Available to Women in New Phenomix Sciences and Hello Alpha Partnership/a>/h3> span classtab-date>Jul 10 | /span> The first-of-its-kind collaboration combines personalized genetic insights with evidence-based treatments to provide accessible and effective obesity care for women a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/10/personalized-obesity-care-genetic-testing-available-to-women-in-new-phenomix-sciences-and-hello-alpha-partnership>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/10/smi-systems-appoints-dr-stefan-hamill-as-vp-of-strategy titleSMi Systems appoints Dr Stefan Hamill as VP of Strategy>SMi Systems appoints Dr Stefan Hamill as VP of Strategy/a>/h3> span classtab-date>Jul 10 | /span> SMi Systems announces the appointment of Dr Stefan Hamill as its Vice President of Strategy. Dr Hamill was formerly a senior analyst at investment banks Numis (now Deutsche Numis) and Peel Hunt, both of which he helped transform into #1 ranked franchises in UK Life Sciences. a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/10/smi-systems-appoints-dr-stefan-hamill-as-vp-of-strategy>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.bio-itworld.com/news/2024/07/08/chargepoint-technology-strengthens-its-global-presence-by-establishing-a-localised-team-in-india-to-support-the-growing-pharma-manufacturing-market titleChargePoint Technology strengthens its global presence by establishing a localised team in India to support the growing pharma manufacturing market>ChargePoint Technology strengthens its global presence by establishing a localised team in India to support the growing pharma manufacturing market/a>/h3> span classtab-date>Jul 08 | /span> a classmore-link hrefhttps://www.bio-itworld.com/news/2024/07/08/chargepoint-technology-strengthens-its-global-presence-by-establishing-a-localised-team-in-india-to-support-the-growing-pharma-manufacturing-market>More/a> /li> /ul> a classview-link href/search-news#?sortPublicationDate%20desc>View more articles/a>/div>script> //Stop buttons from refreshing screen. $(document).ready(function () { //Check for user submit $(#press).on(click, function (event) { event.preventDefault(); }); $(#daily).on(click, function (event) { event.preventDefault(); }); }); //Change news view. function selectNews(evt, sourceName) { // Hide all news. tabcontent document.getElementsByClassName(list-press); for (i 0; i tabcontent.length; i++) { tabcontenti.style.display none; } tabcontent document.getElementsByClassName(list-daily); for (i 0; i tabcontent.length; i++) { tabcontenti.style.display none; } // Make both buttons inactive tabButtons document.getElementsByClassName(tab-button); for (i 0; i tabButtons.length; i++) { tabButtonsi.className tabButtonsi.className.replace( tab-active, ); } // Activate button pressed. evt.currentTarget.className + tab-active; if (sourceName daily) { tabcontent document.getElementsByClassName(list-daily); for (i 0; i tabcontent.length; i++) { tabcontenti.style.display ; } } if (sourceName press) { tabcontent document.getElementsByClassName(list-press); for (i 0; i tabcontent.length; i++) { tabcontenti.style.display ; } } }/script>/div> /div> div classcol-md-4 col-sm-6> div idContentplaceholder1_C018_Col01 classsf_colsIn pad-lr data-sf-elementColumn 2 data-placeholder-labelColumn 2>div > div classsf-Long-text >a hrefhttp://gate250.com/tc2/CHILeadGenBrochure.pdf target_blank>img border0 src/images/librariesprovider76/home/chi-leadgen.png?sfvrsn3db86e69_1 styleborder-width:0px;border-style:solid; titleBio IT World Lead Gen altBio IT World Lead Gen />/a>/div> /div>div classsfContentBlock>br />div iddiv-gpt-ad-1459884088267-3 classtext-center home-spacing>span styledisplay: none;> /span>/div>/div>div > div classsf-Long-text >div classhome-box home-spacing>img altIndustry-spotlight classimageResize src/images/librariesprovider76/home/bit-industry-spotlight-325x35.jpg />div classhome-box-inner>a href target_blank>img classpad-bottom src/images/librariesprovider29/webinars/sponsors/riffyn.jpg stylefloat:left;padding:21px 8px 8px; titleRiffyn />/a> br />p classpad-top>Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.br />a hrefhttp://www.riffyn.com/ target_blank classred>Read more here!/a>/p>/div>/div>/div> /div>div > div classsf-Long-text >div iddiv-gpt-ad-1459884088267-23 classtext-center home-spacing>/div>/div> /div>div > div classsf-Long-text >div classhome-box home-spacing>img altIndustry-spotlight classimageResize src/images/librariesprovider76/home/bit-industry-spotlight-325x35.jpg />div classhome-box-inner>a hrefhttps://www.bio-itworld.com/trends-from-the-trenches>img classpad-bottom src/images/librariesprovider76/home/trenches-side-logo.png stylefloat:left;padding:21px 8px 8px; altTrends from the Trenches />/a> br />p classpad-top>strong>Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next. br />a hrefhttps://www.bio-itworld.com/trends-from-the-trenches classred>Listen today!/a>/strong>/p>strong>/strong>/div>strong>/strong>/div>/div> /div>div > div classsf-Long-text >div classhome-box home-spacing>img classimageResize src/images/librariesprovider76/home/bit-featured-videos-325x35.jpg?sfvrsn6bec1d43_2 />div classrow pad-top>div classcol-md-12>p>a data-togglemodal stylecursor:pointer; data-target#Video-3>img classimageResize src/images/librariesprovider76/home/video-3.png?sfvrsn53aaf8a_1 altSecuring SAP in the Pharmaceutical Industry />/a>/p>a data-togglemodal stylecursor:pointer; data-target#Video-3 data-sf-ec-immutable>p classred styledisplay:block;text-align:center;>b>Securing SAP in the Pharmaceutical Industry/b>/p>/a> /div>/div>div classrow pad-top>div classcol-md-12>p>a data-togglemodal stylecursor:pointer; data-target#Video-4>img classimageResize src/images/librariesprovider76/home/video-1.png?sfvrsn5629d42e_2 altMake your next clinical trial boring />/a>/p>a data-togglemodal stylecursor:pointer; data-target#Video-4 data-sf-ec-immutable>p classred styledisplay:block;text-align:center;>b>Make your next clinical trial boring/b>/p>/a> /div>/div>div classrow pad-top>div classcol-md-12>p>a data-togglemodal stylecursor:pointer; data-target#Video-1>img classimageResize src/images/librariesprovider76/home/video-2.png?sfvrsnedc153cc_2 altSlope makes your clinical trials worry-free />/a>/p>a data-togglemodal stylecursor:pointer; data-target#Video-1 data-sf-ec-immutable>p classred styledisplay:block;text-align:center;>b>Slope makes your clinical trials worry-free/b>/p>/a> /div>/div>hr />p classred text-center>a href/BioITVideos data-sf-ec-immutable>b>View More Industry Videos/b>/a>/p>/div>!-- Video 4 -->div classmodal fade centered-modal featured-video idVideo-4 tabindex-1 roledialog aria-labelledbymyModalLabel>div classmodal-dialog>div classmodal-header>button typebutton classclose video-close data-dismissmodal aria-labelClose>span aria-hiddentrue>×/span>/button>/div>div classmodal-content>div classmodal-body modal-video-player idyt-player>div classvideoWrapper>iframe width560 height315 srchttps://chi-cloud.s3.amazonaws.com/webinars/BIT/22/SLOPE-Sponsor-V2.mp4 frameborder0 allowfullscreen>/iframe>/div>/div>/div>/div>/div>!-- Video 1 -->div classmodal fade centered-modal featured-video idVideo-1 tabindex-1 roledialog aria-labelledbymyModalLabel>div classmodal-dialog>div classmodal-header>button typebutton classclose video-close data-dismissmodal aria-labelClose>span aria-hiddentrue>×/span>/button>/div>div classmodal-content>div classmodal-body modal-video-player idyt-player>div classvideoWrapper>iframe width560 height315 srchttps://chi-cloud.s3.amazonaws.com/webinars/BIT/22/Slope.mp4 frameborder0 allowfullscreen>/iframe>/div>/div>/div>/div>/div>!-- Video 1 -->div classmodal fade centered-modal featured-video idVideo-3 tabindex-1 roledialog aria-labelledbymyModalLabel>div classmodal-dialog>div classmodal-header>button typebutton classclose video-close data-dismissmodal aria-labelClose>span aria-hiddentrue>×/span>/button>/div>div classmodal-content>div classmodal-body modal-video-player idyt-player>div classvideoWrapper>iframe width560 height315 srchttps://chi-cloud.s3.amazonaws.com/Videos/BIT-Hompage/RX-SAP-Troy-Ament-Aidan-Walden-Fortinet.mp4 frameborder0 allowfullscreen>/iframe>/div>/div>/div>/div>/div>/div> /div>/div> /div> div classcol-sm-12 col-md-3> div idContentplaceholder1_C018_Col02 classsf_colsIn pad-lr data-sf-elementColumn 3 data-placeholder-labelColumn 3>div > div classsf-Long-text >div classtwitterFeed>a classtwitter-timeline data-height600 hrefhttps://twitter.com/bioitworld>Tweets by bioitworld/a>/div>/div> /div>div classsfContentBlock>div iddiv-gpt-ad-1459884088267-5 classtext-center home-spacing> /div>/div>div > div classsf-Long-text >div iddiv-gpt-ad-1459884088267-4 classtext-center home-spacing>/div>/div> /div>/div> /div>/div>div classrow data-sf-elementRow> div classcol-sm-5> div idContentplaceholder1_C017_Col00 classsf_colsIn pad-lr data-sf-elementColumn 1 data-placeholder-labelColumn 1>/div> /div> div classcol-sm-4> div idContentplaceholder1_C017_Col01 classsf_colsIn pad-lr data-sf-elementColumn 2 data-placeholder-labelColumn 2>/div> /div> div classcol-sm-3> div idContentplaceholder1_C017_Col02 classsf_colsIn pad-lr data-sf-elementColumn 3 data-placeholder-labelColumn 3>/div> /div>/div>script typetext/javascript>googletag.cmd.push(function() { googletag.display(div-gpt-ad-1459884088267-1); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1459884088267-21); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1459884088267-2); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1459884088267-22); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1459884088267-3); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1459884088267-4); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1459884088267-5); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1459884088267-6); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1459884088267-7); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1459884088267-8); });/script>div > div classsf-Long-text >/div> /div>div classrow data-sf-elementRow> div classcol-sm-9> div idContentplaceholder1_T3B9CFFA2006_Col00 classsf_colsIn pad-lr data-sf-elementColumn 1 data-placeholder-labelColumn 1>div > div classsf-Long-text >div iddiv-gpt-ad-1459884088267-21 classhome-spacing hidden-xs pad-left pad-bottom>/div>/div> /div>/div> /div> div classcol-sm-3> div idContentplaceholder1_T3B9CFFA2006_Col01 classsf_colsIn pad-lr data-sf-elementColumn 2 data-placeholder-labelColumn 2>div > div classsf-Long-text >div iddiv-gpt-ad-1459884088267-22 classad-top-right>/div>/div> /div>/div> /div>/div> /div> /div> /div> footer> /div>div > div classsf-Long-text >div classfooter>div classcontainer>div classrow>div classcol-sm-3 col-xs-12>div classfooter-small>div classfooter-small-inner>img altCHI | Cambridge HealthTech Institute classCII-footer src/UploadedImages/CHI-logo.png data-sf-ec-immutable />br />p>250 First Avenue, Suite 300br />Needham, MA 02494br />br />P: 781.972.5400br />F: 781.972.5425 br />E: a hrefmailto:chi@healthtech.com?cdtConferenceId404272006.1663694140&cdtRollupId404272006.1663694140 data-sf-ec-immutable>chi@healthtech.com/a> /p>div classrow>div classcol-sm-12 footer-social>a hrefhttps://twitter.com/CHI_Healthtech data-sf-ec-immutable>img src/images/default-source/social/twitter-gray.png?sfvrsnbac909e7_7 alt classfooter-social-icons />/a> a hrefhttps://www.linkedin.com/company/cambridge-healthtech-institute data-sf-ec-immutable>img src/images/default-source/social/linkedin-gray.png?sfvrsned70471e_4 classfooter-social-icons alt />/a> a hrefhttps://www.facebook.com/HealthtechConferences data-sf-ec-immutable>img src/images/default-source/social/facebook-gray.png?sfvrsn35d4a48c_4 classfooter-social-icons alt />/a> /div>/div>/div>/div>/div>div classcol-sm-4 footer-border hidden-xs>div classrow>div classcol-sm-12>p>Life Science Portals/p>/div>div classcol-sm-6>p>a hrefhttp://biologicaltherapeutics.cambridgeinnovationinstitute.com/home>Biological Therapeutic Products/a>/p>p>a hrefhttp://biomarkers.cambridgeinnovationinstitute.com/home>Biomarkers & Diagnostics/a>/p>p>a hrefhttp://biopharmastrategy.cambridgeinnovationinstitute.com/home>Biopharma Strategy/a>/p>p>a hrefhttps://bioprocessing.cambridgeinnovationinstitute.com/home>Bioprocess & Manufacturing/a>/p>p>a hrefhttp://chemistry.cambridgeinnovationinstitute.com/home>Chemistry/a>/p>p>a hrefhttp://clinicaltrials.cambridgeinnovationinstitute.com/home>Clinical Trials &br data-sf-ec-immutable />Translational Medicine/a>/p>p>a hrefhttp://druganddevice.cambridgeinnovationinstitute.com/home>Drug & Device Safety/a>/p>/div>div classcol-sm-6>p>a hrefhttp://drugdevelopment.cambridgeinnovationinstitute.com/home>Drug Discovery & Development/a>/p>p>a hrefhttp://drugtargets.cambridgeinnovationinstitute.com/home>Drug Targets/a>/p>p>a hrefhttp://healthcare.cambridgeinnovationinstitute.com/home>Healthcare/a>/p>p>a hrefhttp://it.cambridgeinnovationinstitute.com/home>IT, AI, ML & Informatics/a>/p>p>a hrefhttp://techtools.cambridgeinnovationinstitute.com/home>Technology & Tools Forbr data-sf-ec-immutable />Life Science/a>/p>p>a hrefhttp://therapeutics.cambridgeinnovationinstitute.com/home>Therapeutic Indications/a>/p>p>a hrefhttps://www.cambridgeinnovationinstitute.com/vip-series data-sf-ec-immutable>Venture, Innovation, and Partnering/a>/p>/div>/div>/div>div classcol-sm-3 footer-border hidden-xs>p>CHI Divisions/p>p>a hrefhttps://www.healthtech.com/?cdtConferenceId404272006.1663694140&cdtRollupId404272006.1663694140 data-sf-ec-immutable>Conferences/a>/p>p>a hrefhttps://www.insightpharmareports.com/ data-sf-ec-immutable>Reports & Market Research/a>/p>p>a hrefhttps://www.barnettinternational.com/ data-sf-ec-immutable>Barnett Educational Services/a>/p>p>a hrefhttps://www.healthtech.com/publishing data-sf-ec-immutable>News & Advertising/a>/p>p>a hrefhttps://proservices.healthtech.com/?cdtConferenceId404272006.1663694140&cdtRollupId404272006.1663694140 data-sf-ec-immutable>Professional Services/a>/p>/div>div classcol-sm-2 footer-border hidden-xs>p>Corporate Information/p>p>a hrefhttps://www.cambridgeinnovationinstitute.com/ data-sf-ec-immutable>Cambridge Innovationbr />Institute/a>/p>p>a hrefhttps://www.cambridgeinnovationinstitute.com/Executive-Team/ data-sf-ec-immutable>Executive Team/a>/p>p>a hrefhttps://www.cambridgeinnovationinstitute.com/Testimonials/ data-sf-ec-immutable>Testimonials/a>/p>p>a hrefhttps://www.cambridgeinnovationinstitute.com/mailing-list.html data-sf-ec-immutable>Mailing List/a>/p>p>a hrefhttps://www.cambridgeinnovationinstitute.com/Careers/ titleCareers data-sf-ec-immutable>Careers/a>/p>hr />p>a hrefhttps://www.cambridgeinnovationinstitute.com/request-information data-sf-ec-immutable>Request Information/a>/p>p>a hrefhttps://www.cambridgeinnovationinstitute.com/Privacy-Policy/ data-sf-ec-immutable>Privacy Policy/a>/p>/div>/div>/div>/div>/div> /div> /footer> script src/Frontend-Assembly/Telerik.Sitefinity.Frontend/Mvc/Scripts/Bootstrap/js/bootstrap.min.js?packageBootstrap&vMTQuMi43OTAwLjA%3d typetext/javascript>/script>script src/js/menu-wsub.js typetext/javascript>/script>script typeapplication/json idPersonalizationTracker> {IsPagePersonalizationTarget:false,IsUrlPersonalizationTarget:true,PageId:5cd605f7-32f9-4674-89ee-c8c7cb9b449a}/script>script typetext/javascript src/WebResource.axd?dOiw5o8i74rDb2VpVaCaMSouKRnJ2rn_cgRr8eXgFzWmU6yVv8fmvjGNlDReMboLSikSmK5y_KsDt9j-18b7ZqBNiz0-92AjY43-6qMcq4O__3MjW1Pd6kS68TTYuxCxnF4HnqcusO3ivgfHZzR9usujs8YAzvYku29ledrs3mezPir5ikBP0Pxh4nDmiJEk2WgW0YVPdsdMlu69MVd6jI94nvC3-40pMaRxtm9HTV2I1&t637922505260000000>/script>script typetext/javascript>var link document.createElement(link);link.id dynamic-favicon;link.rel shortcut icon;link.href /images/librariesprovider29/template-images/bit-favicon-32x32.png;document.head.appendChild(link);/script>script typetext/javascript>$(#Video-3).on(hidden.bs.modal, function (e) { $(.videoWrapper).find(iframe).attr(src, );});$(#Video-1).on(hidden.bs.modal, function (e) { $(.videoWrapper).find(iframe).attr(src, );});$(#Video-4).on(hidden.bs.modal, function (e) { $(.videoWrapper).find(iframe).attr(src, );});/script>script typetext/javascript> $(.Tab2).hide(); $(#press-release).click(function(){ $(.Tab2).show(750); $(.Tab1).hide(250); $(.Tab2Btn).addClass(active); $(.Tab1Btn).removeClass(active); }); $(#upcoming).click(function () { $(.Tab1).show(750); $(.Tab2).hide(250); $(.Tab1Btn).addClass(active); $(.Tab2Btn).removeClass(active); });/script> /body> /html>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]